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jogging. However, this conclusion cannot be drawn
from the data presented.
Schnohr et al. claim to have analyzed the quantity,
frequency, and pace of jogging. However, only fre-
quency was assessed, and instead of quantity and pace,
they assessed time spent jogging and perceived in-
tensity, respectively. A ﬁt person may cover a much
longer distance during the same time as an unﬁt person
and perceive the same absolute intensity as light
instead of strenuous. This is a serious problem, because
cardiorespiratory ﬁtness is strongly related to mortality
and to the analyzed exposures. This confounding was
not taken into account, and adjustment for ﬁtness
could have resulted in the opposite conclusion.
None of the conclusions are justiﬁed by the
statistical analysis. In the analysis of the 3 exposures—
quantity, frequency, and pace of jogging—the conﬁ-
dence intervals of the subgroups overlap, which
means there are no differences between the groups.
Most of the subgroups include only 1 to 5 cases, and
the conclusions based on this few cases cannot be
justiﬁed. An analysis in which all of the jogging groups
are merged could make statistical sense, and it could
conclude that there is a substantial beneﬁt to jogging,
but not how fast, how long, or how frequently jogging
should take place.
The investigators concluded that there is a U-shape
between the dose of jogging and mortality. The deﬁ-
nition of what is light, moderate, and strenuous
jogging is problematic, because the study did not
assess these exposures, as previously mentioned. The
strenuous group experienced only 2 deaths, and to
draw conclusions of a U-shape on the basis of 2 cases
cannot be justiﬁed. The investigators do not describe
how the 413 joggers in the reference group were
selected from among the 3,950 nonjoggers, but it
is obvious that an age difference of approximately
20 years between the reference group and all sub-
groups of joggers points to a severe selection bias,
which makes a comparison difﬁcult.
Finally, it is surprising that the investigators did
not discuss in detail why 2 recently published studies
that analyzed walking (2) and cycling (3) from the
same data came up with the opposite conclusion in
relation to intensity and duration of physical activity.*Lars Bo Andersen, Dr Med Sci
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What Makes the Difference?We appreciate the ﬁndings reported by Schnohr et al.
(1), but we feel that insufﬁcient attention has been
paid to the consequences of pace categorization
by self-reporting. The investigators demonstrate a
U-shaped relationship between the dose of jogging
and all-cause mortality. Joggers were categorized as
light, moderate, or strenuous joggers on the basis of
the quantity of jogging and the self-reported pace
(slow, average, fast). The use of the self-reported
(perceived) pace makes sense from a practical and
clinical point of view, but it is unjustiﬁed to assign
ﬁxed amounts of miles per hour to the pace cate-
gories without considering individual ﬁtness levels.
Everybody will agree that a pace of 7 mph will
generate different cardiovascular responses and will
be perceived differently by a 35-year-old elite runner
than an 85-year-old amateur runner due to the huge
differences in aerobic power (cardiovascular ﬁtness)
(2). Thus, the U-shaped association between the dose
of jogging and mortality is likely to be true when
based on the individually perceived pace, but is very
likely wrong when based on absolute values. In our
opinion, this is a critical point, because a pace of 7
mph is fast for a novice or an amateur runner but is a
perceived slower pace for an elite runner. Profes-
sional endurance athletes usually perform >80% of
their training sessions at light intensities (50% to
70% of their maximal heart rate) (3), and therefore,
would be rated as moderate or even light joggers
according to the categorization applied by Schnohr
et al. (1). This is compared with novice runners who
often train at too high intensities. Furthermore,
numerous middle-aged and poorly prepared recrea-
tional runners start strenuous running programs af-
ter cardiovascular disease diagnosis. This means that
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2672over-ambitious amateur runners, rather than elite
runners, are placed at the rising slope of the U-sha-
ped relationship between jogging dose and all-cause
mortality. Therefore, novice and amateur runners
could not only optimize their running training and
performance but also their cardiovascular health by
following modern training methods used by elite
runners.*Martin Burtscher, MD, PhD
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The Copenhagen City Heart StudyWe read with great interest both the paper by
Schnohr et al. (1) on the dose of jogging and mor-
tality in the CCHS (Copenhagen City Heart Study)
cohort and the editorial comment by Lee et al. (2).
There is one major confounder in the original paper
we would like to emphasize: sedentary nonjoggers
were more often women (57%) and strenuous joggers
were mostly men (80%). This unbalance is of utter-
most importance for mortality studies because the
men–women life expectancy difference at 44 years
(mean baseline age in the CCHS) was –3.9 years in
Denmark in 2001 (Eurostat). In a previous paper, the
same Danish team reported that jogging could in-
crease survival by 6.2 years in men and 5.6 years in
women (3). Therefore, the effect of sex on the
outcome (mortality) is of the same order of magni-
tude as the effect of the variable of interest(jogging). The only reasonable approach in that case
is to analyze men and women in 2 separate studies.
There is no need to use statistics to test the hy-
pothesis of an effect of sex on mortality, because
this effect is not a hypothesis but a fact. Pooling men
and women together and adjusting by sex can only
decrease the power of the analyses and fails to show
a potential difference between sedentary nonjoggers
and strenuous joggers. A simple rule of thumb
calculation with the previously described estimates
of both sex and jogging effects shows that, compared
with a putative all-men sedentary nonjogger group
of the same age, the sedentary nonjogger and
strenuous jogger groups of the CCHS would have an
increased life expectancy of 4.2 and 3 years,
respectively, which could mistakenly be interpreted
as an increased risk for the strenuous joggers.
Therefore, we strongly recommend men and women
being considered separately when conducting mor-
tality studies.*Olivier Luc Charansonney, MD, MSc
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Mortality Versus LongevityWe read, with great interest, the paper by Schnohr
et al. (1), who investigated the association between
jogging and long-term all-cause mortality. The in-
vestigators reported that light and moderate joggers
had lower mortality rates (hazard ratio [HR]: 0.22;
95% conﬁdence intervals [CI]: 0.10 to 0.47 and HR:
0.66; 95% CI: 0.32 to 1.38, respectively) compared
